Bioton S.a. Bioton S.a.

Bioton S.a.

BIO

Rank in Stocks #20836
Bioton S.A. operates as a biotechnology company, engaged in the creation,... Bioton S.A. operates as a biotechnology company, engaged in the creation, production, distribution, and commercialization of a diverse array of pharmaceuticals, medicinal preparations, and active pharmaceutical ingredients. Its primary focus is on diabetes management, offering products such as recombinant human and conventional insulin, alongside oral anti-diabetic medications. The company's portfolio extends to include dietary supplements, blood glucose monitoring strips, and over-the-counter solutions for diabetics. Key insulin products include Gensulin N, Gensulin R, and Gensulin M30, available in vials and cartridges. Complementing these are advanced delivery and monitoring systems like the GensuPen 2 automatic injection device and the GensuCare glucometer for diabetes monitoring, alongside essential needles. Bioton S.A. distributes its offerings across numerous international markets, including Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. Beyond its core product activities, the company also undertakes advertising, advisory services, and general corporate management. Founded in 1989, its headquarters are situated in Ozarów Mazowiecki, Poland.
Share Price
$0.8609826
Last synced: 2026-11-16
Market Cap
$73.93M
Change (1 day)
0.38%
Change (1 year)
-24.21%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Category

Healthcare
EPS for Bioton S.a. (BIO)
EPS as of September 2026 TTM: $-0.04
According to Bioton S.a.'s latest financial reports, its current EPS (TTM) is $-0.04. At the end of 2025 the company had an EPS of $0.01, an increase over its 2024 EPS of $-0.04.
EPS history for Bioton S.a. from 2005 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.04 -450.00%
2025 $0.01 -125.11%
2024 $-0.04 -753.73%
2023 $0.01 76.32%
2022 0.00 -54.22%
2021 $0.01 -92.26%
2020 $0.11 -127.59%
2019 $-0.39 -569.12%
2018 $0.08 -441.15%
2017 $-0.02 -69.20%
2016 $-0.08 -94.91%
2015 $-1.55 -13,817.70%
2014 $0.01 -144.84%
2013 $-0.03 -114.69%
2012 $0.17 -139.70%
2011 $-0.43 -158.44%
2010 $0.74 -115.03%
2009 $-4.92 100.35%
2008 $-2.46 -676.53%
2007 $0.43 -66.96%
2006 $1.29 201.29%
2005 $0.43 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 2,442.86%
US
$15.66 -44,842.86%
US
$-7.07 20,100.00%
US
$-5.29 15,014.29%
AU
$12.73 -36,477.71%
BE

Questions about Bioton S.a.'s earnings per share (EPS)

What is Bioton S.a.'s earnings per share (EPS)?

Bioton S.a.'s earnings per share (EPS) over the last twelve months is $-0.04, as of Sep 2026.

What was Bioton S.a.'s earnings per share (EPS) in 2025?

In 2025, Bioton S.a.'s earnings per share (EPS) was $0.01, compared with $-0.04 in 2024.

How has Bioton S.a.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, Bioton S.a.'s earnings per share (EPS) went from $0.11 to $0.01, an average decline of 38.10% a year.

How does Bioton S.a.'s earnings per share (EPS) compare with similar companies?

Bioton S.a.'s earnings per share (EPS) ($-0.04) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.